Oncolytics Biotech (ONCY) Short Interest Ratio & Short Volume → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free ONCY Stock Alerts $1.08 +0.02 (+1.89%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Oncolytics Biotech Short Interest DataCurrent Short Volume928,100 sharesPrevious Short Volume930,700 sharesChange Vs. Previous Month-0.28%Dollar Volume Sold Short$983,786.00Short Interest Ratio / Days to Cover2.5Last Record DateApril 15, 2024Outstanding Shares75,420,000 sharesPercentage of Shares Shorted1.23%Today's Trading Volume302,083 sharesAverage Trading Volume369,111 sharesToday's Volume Vs. Average82% Short Selling Oncolytics Biotech ? Sign up to receive the latest short interest report for Oncolytics Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatONCY Short Interest Over TimeONCY Days to Cover Over TimeONCY Percentage of Float Shorted Over Time Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Oncolytics Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024928,100 shares $983,786.00 -0.3%N/A2.5 $1.06 3/31/2024930,700 shares $986,542.00 +1.2%N/A2.3 $1.06 3/15/2024919,700 shares $909,491.33 -11.6%N/A2.2 $0.99 2/29/20241,040,000 shares $1.19 million +12.6%N/A2.3 $1.14 2/15/2024923,400 shares $1.07 million +38.7%N/A2.2 $1.16 1/31/2024666,000 shares $792,540.00 -40.0%N/A1.5 $1.19 Get the Latest News and Ratings for ONCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,110,000 shares $1.35 million +0.9%N/A2.6 $1.22 12/31/20231,100,000 shares $1.49 million -7.6%N/A2.5 $1.35 12/15/20231,190,000 shares $1.61 million -16.8%N/A2.9 $1.35 11/30/20231,430,000 shares $2.07 million -4.0%N/A3.6 $1.45 11/15/20231,490,000 shares $2.21 million -6.9%N/A3.4 $1.48 10/31/20231,600,000 shares $2.66 million +12.7%N/A3.2 $1.66 10/15/20231,420,000 shares $2.64 million -2.1%N/A2.3 $1.86 9/30/20231,450,000 shares $3.16 million -8.8%N/A2.2 $2.18 9/15/20231,590,000 shares $3.42 million -2.5%N/A1.9 $2.15 8/31/20231,630,000 shares $3.73 million +38.1%N/A1.4 $2.29 8/15/20231,180,000 shares $2.43 million -38.9%N/A1 $2.06 7/31/20231,930,000 shares $4.86 million +39.9%N/A1.9 $2.52 7/15/20231,380,000 shares $4.07 million +12.2%N/A1.6 $2.95 6/30/20231,230,000 shares $3.20 million +256.3%N/A1.6 $2.60 6/15/2023345,200 shares $673,140.00 +6.0%N/A0.6 $1.95 5/31/2023325,600 shares $527,472.00 +104.3%N/A1.4 $1.62 5/15/2023159,400 shares $261,416.00 +133.7%N/A0.9 $1.64 4/30/202368,200 shares $99,565.18 -8.2%N/A0.4 $1.46 4/15/202374,300 shares $85,445.00 -35.8%N/A0.4 $1.15 3/31/2023115,800 shares $138,960.00 -45.8%N/A0.6 $1.20 3/15/2023213,700 shares $284,221.00 +15.1%N/A1 $1.33 2/28/2023185,700 shares $284,121.00 +4.6%N/A0.7 $1.53 2/15/2023177,500 shares $296,425.00 +29.5%N/A0.6 $1.67 1/31/2023137,100 shares $244,038.00 +45.9%N/A0.4 $1.78 1/15/202394,000 shares $155,100.00 +57.5%N/A0.3 $1.65 12/30/202259,700 shares $97,311.00 -54.8%N/A0.2 $1.63 12/15/2022132,200 shares $241,926.00 +91.9%N/A0.5 $1.83 11/30/202268,900 shares $121,264.00 -38.0%N/A0.4 $1.76 11/15/2022111,200 shares $173,472.00 -3.1%N/A1 $1.56 10/31/2022114,700 shares $144,522.00 -29.9%N/A1.2 $1.26 10/15/2022163,500 shares $199,470.00 +1.5%N/A1.9 $1.22 9/30/2022161,100 shares $198,153.00 -19.2%N/A1.9 $1.23 9/15/2022199,300 shares $259,090.00 -23.1%N/A1.9 $1.30 8/31/2022259,000 shares $371,846.30 +9.5%N/A2.2 $1.44“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). ONCY Short Interest - Frequently Asked Questions What is Oncolytics Biotech's current short interest? Short interest is the volume of Oncolytics Biotech shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 928,100 shares of ONCY short. Learn More on Oncolytics Biotech's current short interest. What is a good short interest ratio for Oncolytics Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ONCY shares currently have a short interest ratio of 2.0. Learn More on Oncolytics Biotech's short interest ratio. Is Oncolytics Biotech's short interest increasing or decreasing? Oncolytics Biotech saw a decline in short interest in April. As of April 15th, there was short interest totaling 928,100 shares, a decline of 0.3% from the previous total of 930,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Oncolytics Biotech's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Oncolytics Biotech: InflaRx (0.22%), Aileron Therapeutics, Inc. (0.31%), Marinus Pharmaceuticals, Inc. (8.23%), Affimed (1.66%), Leap Therapeutics, Inc. (6.19%), LifeVantage Co. (0.66%), Chimerix, Inc. (1.66%), Spero Therapeutics, Inc. (0.95%), Connect Biopharma Holdings Limited (0.16%), Tempest Therapeutics, Inc. (6.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Oncolytics Biotech stock? Short selling ONCY is an investing strategy that aims to generate trading profit from Oncolytics Biotech as its price is falling. ONCY shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncolytics Biotech? A short squeeze for Oncolytics Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ONCY, which in turn drives the price of the stock up even further. How often is Oncolytics Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ONCY, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: InflaRx Short Squeeze Aileron Therapeutics Short Squeeze Marinus Pharmaceuticals Short Squeeze Affimed Short Squeeze Leap Therapeutics Short Squeeze LifeVantage Short Squeeze Chimerix Short Squeeze Spero Therapeutics Short Squeeze Connect Biopharma Short Squeeze Tempest Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ONCY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersI’m afraid WWIII is a very real possibility Porter & Company